Adicet Bio, Inc. Share Price
ACETAdicet Bio, Inc. Stock Performance
Open $7.55 | Prev. Close $7.59 | Circuit Range N/A |
Day Range $7.54 - $7.65 | Year Range $0.46 - $8.83 | Volume 2,898 |
Average Traded $7.58 |
Adicet Bio, Inc. Share Price Chart
About Adicet Bio, Inc.
Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. It offers gamma delta T cells engineered with chimeric antigen receptors (CARs) to facilitate durable activity in patients. The company's lead product candidate is ADI-001, an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, which is in Phase I clinical trial for the potential treatment of autoimmune diseases and relapsed/refractory B-cell non-hodgkin's lymphoma. It also develops ADI-270, an armored gamma delta CAR T cell product candidate to treat multiple CD70+ solid tumor and hematological malignancies indications, with renal cell carcinoma. The company was founded in 2014 and is based in Boston, Massachusetts.
Adicet Bio, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
30-Apr-26 | $7.55 | $7.54 | +0.00% |
30-Apr-26 | $7.55 | $7.54 | -0.66% |
29-Apr-26 | $7.46 | $7.59 | -2.13% |
28-Apr-26 | $7.80 | $7.76 | -2.33% |
27-Apr-26 | $8.09 | $7.95 | +1.08% |
24-Apr-26 | $7.95 | $7.86 | -1.38% |
23-Apr-26 | $7.97 | $7.97 | -4.38% |